Canfite earnings
WebMar 30, 2024 · Can-Fite Biopharma Ltd ADR (CANF) reported a 4th Quarter December 2024 loss of $1.11 per share on revenue of $0.2 million. The consensus estimate was a … Web© 2024 Can-Fite All Rights Reserved. BrandWiz - Branding - Branding
Canfite earnings
Did you know?
WebFind real-time CANF - Can Fite Biopharma Ltd stock quotes, company profile, news and forecasts from CNN Business. WebDec 31, 2024 · Earnings Release. PDF HTML 20-F Filing. PDF HTML. XBRL. ZIP XLS HTML. Company Overview. Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: …
WebCan Fite is trading at 3.24 as of the 14th of February 2024. This is a -6.36 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.0. Stay informed regarding Can Fite Stock and understand the value of trading Can Fite now. Get the latest Can Fite detailed stock quotes, stock trade data, stock price info, and performance … WebJan 17, 2024 · Meanwhile, the Medical sector has returned an average of -12.7% on a year-to-date basis. This means that CanFite Biopharma Ltd is performing better than its sector in terms of year-to-date returns. Cellectar Biosciences, Inc. (CLRB) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the ...
Web2 days ago · Can-Fite BioPharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2.. CI. 03/17: Can-fite to conduct meetings at the bio-europe spring conference with pharma companies .. AQ. 03/13: Can-Fite to Treat Decompensated Liver Cirrhosis Patients with Namodenoson Under Compass.. CI. WebEarnings estimates and surprises for Can-Fite Biopharma Ltd ADR (CANF) are an important tool used to evaluate the company's overall strength and value of the stock. …
WebApr 7, 2024 · First quarter 2024 earnings released: US$0.004 loss per share (vs US$0.025 loss in 1Q 2024) May 28. No longer forecast to breakeven May 28. Can-Fite BioPharma …
WebCan-Fite Biopharma Ltd. ADR analyst ratings, historical stock prices, earnings estimates & actuals. CANF updated stock price target summary. css cheerfulWebEarnings Estimates are available only for US equities. >Earnings Surprises. The first table on the Estimates page compares Actual vs. Estimated earnings for the last four … ear examsWebNext Earnings Date: The next reported earnings date. Stocks whose Next Earnings Date falls within the next 7 days are highlighted in red. Annual Dividend & Yield: The indicated annual dividend rate and yield, calculated from the latest dividend. The dividend rate is the portion of a company's profit paid to shareholders, quoted as the dollar ... css chelmsfordWebThe Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from … ear exceptions 740WebMar 5, 2024 · Earnings Estimate Revisions for CanFite Biopharma Ltd For the fiscal year ending December 2024, this company is expected to earn -$1.26 per share, which is a … ear exam ear waxWebJul 26, 2024 · CanFite Biopharma Ltd (CANF) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ... css che coseWebMar 30, 2024 · Can-Fite Biopharma Ltd ADR (CANF) reported a 4th Quarter December 2024 loss of $1.11 per share on revenue of $0.2 million. The consensus estimate was a loss of $0.57 per share on revenue of $0.3 million. Revenue fell 3.4% compared to the same quarter a year ago. css chepo